Orasure Technologies (OSUR) Cash from Financing Activities (2010 - 2025)
Orasure Technologies' (OSUR) quarterly Cash from Financing Activities came in at -$5.1 million in Q3 2025, down 599.59% year-on-year from $1.0 million in Q3 2024, and up 12.4% quarter-over-quarter from -$5.8 million in Q2 2025.
Orasure Technologies (OSUR) Cash from Financing Activities (2010 - 2025) Analysis & Trends
Orasure Technologies has disclosed Cash from Financing Activities across 16 years of filings, most recently posting -$5.1 million for Q3 2025.
- Cash from Financing Activities for Q3 2025 came in at -$5.1 million, down 599.59% year-over-year; the trailing twelve-month figure through Sep 2025 was -$11.9 million (down 170.16% YoY), and the FY2024 annual result was -$4.2 million, down 38.14% from the prior year.
- Cash from Financing Activities came in at -$5.1 million for Q3 2025 at Orasure Technologies, up from -$5.8 million in the prior quarter.
- In the past five years, Cash from Financing Activities ranged from a high of $235000.0 in Q4 2021 to a low of -$5.8 million in Q2 2025.
- The 5-year median for Cash from Financing Activities is -$801000.0 (2022), against an average of -$1.4 million.
- Across the five-year window, Cash from Financing Activities surged 68.73% in 2024 and plunged 599.59% in 2025, its largest moves.
- Orasure Technologies' Cash from Financing Activities stood at $235000.0 in 2021, then slumped by 440.85% to -$801000.0 in 2022, then soared by 55.68% to -$355000.0 in 2023, then soared by 68.73% to -$111000.0 in 2024, then tumbled by 4475.68% to -$5.1 million in 2025.
- The last three Cash from Financing Activities figures came in at -$5.1 million (Q3 2025), -$5.8 million (Q2 2025), and -$953000.0 (Q1 2025), per Business Quant data.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Cash from Financing (Qtr) |
|---|---|---|---|---|---|
| 1 | Intuitive Surgical | 148.09 Bn | 143.69 Bn | 1.83 Bn | -1.35 Bn |
| 2 | Becton Dickinson | 41.00 Bn | 39.99 Bn | 2.15 Bn | -414.00 Mn |
| 3 | Medline | 30.38 Bn | 36.22 Bn | 1.84 Bn | -13.00 Mn |
| 4 | Resmed | 28.22 Bn | 26.56 Bn | 890.98 Mn | -255.24 Mn |
| 5 | West Pharmaceutical Services | 23.72 Bn | 23.19 Bn | 296.40 Mn | -308.70 Mn |
| 6 | Solventum | 13.33 Bn | 13.33 Bn | 1.10 Bn | -50.00 Mn |
| 7 | Cooper Companies | 13.12 Bn | 12.99 Bn | 735.40 Mn | -75.80 Mn |
| 8 | Align Technology | 12.86 Bn | 11.80 Bn | 736.59 Mn | -48.13 Mn |
| 9 | Baxter International | 10.51 Bn | 8.47 Bn | 891.00 Mn | -11.00 Mn |
| 10 | Orasure Technologies | 304.09 Mn | 104.81 Mn | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Sep 30, 2025 | -5.08 Mn |
| Sep 30, 2025 | -5.08 Mn |
| Jun 30, 2025 | -5.80 Mn |
| Jun 30, 2025 | -5.80 Mn |
| Mar 31, 2025 | -953,000.00 |
| Mar 31, 2025 | -953,000.00 |
| Dec 31, 2024 | -111,000.00 |
| Dec 31, 2024 | -111,000.00 |
| Sep 30, 2024 | -726,000.00 |
| Sep 30, 2024 | -726,000.00 |
| Jun 30, 2024 | -2.04 Mn |
| Jun 30, 2024 | -2.04 Mn |
| Mar 31, 2024 | -1.30 Mn |
| Mar 31, 2024 | -1.30 Mn |
| Dec 31, 2023 | -355,000.00 |
| Dec 31, 2023 | -355,000.00 |
| Sep 30, 2023 | -705,000.00 |
| Sep 30, 2023 | -705,000.00 |
| Jun 30, 2023 | -632,000.00 |
| Jun 30, 2023 | -632,000.00 |